Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-cash Items (2020 - 2022)

Caribou Biosciences (CRBU) has disclosed Non-cash Items for 3 consecutive years, with $31.5 million as the latest value for Q2 2022.

  • Quarterly Non-cash Items rose 275.0% to $31.5 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $31.5 million through Jun 2022, up 275.0% year-over-year, with the annual reading at $1.3 million for FY2021, 81.3% down from the prior year.
  • Non-cash Items for Q2 2022 was $31.5 million at Caribou Biosciences, up from $1.6 million in the prior quarter.
  • The five-year high for Non-cash Items was $50.1 million in Q4 2021, with the low at $1.6 million in Q1 2022.
  • Average Non-cash Items over 3 years is $16.1 million, with a median of $8.4 million recorded in 2021.
  • The sharpest move saw Non-cash Items soared 622.83% in 2021, then tumbled 83.26% in 2022.
  • Over 3 years, Non-cash Items stood at $6.9 million in 2020, then skyrocketed by 622.83% to $50.1 million in 2021, then crashed by 37.11% to $31.5 million in 2022.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $31.5 million, $1.6 million, and $50.1 million for Q2 2022, Q1 2022, and Q4 2021 respectively.